Arrowstreet Capital Limited Partnership Trims Position in Select Medical Holdings Corporation $SEM

Arrowstreet Capital Limited Partnership decreased its holdings in Select Medical Holdings Corporation (NYSE:SEMFree Report) by 8.7% in the second quarter, HoldingsChannel.com reports. The fund owned 484,290 shares of the health services provider’s stock after selling 45,874 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Select Medical were worth $7,352,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in SEM. Advisors Asset Management Inc. raised its holdings in Select Medical by 13.2% in the 2nd quarter. Advisors Asset Management Inc. now owns 7,135 shares of the health services provider’s stock worth $108,000 after purchasing an additional 834 shares in the last quarter. Brucke Financial Inc. increased its position in shares of Select Medical by 7.0% during the second quarter. Brucke Financial Inc. now owns 13,638 shares of the health services provider’s stock valued at $207,000 after buying an additional 898 shares during the period. Caitong International Asset Management Co. Ltd raised its stake in Select Medical by 61.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider’s stock worth $45,000 after buying an additional 1,030 shares in the last quarter. PNC Financial Services Group Inc. lifted its holdings in Select Medical by 15.9% in the second quarter. PNC Financial Services Group Inc. now owns 8,828 shares of the health services provider’s stock worth $134,000 after buying an additional 1,208 shares during the period. Finally, Teacher Retirement System of Texas boosted its position in Select Medical by 9.3% during the 2nd quarter. Teacher Retirement System of Texas now owns 17,590 shares of the health services provider’s stock valued at $267,000 after acquiring an additional 1,498 shares in the last quarter. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Stock Up 2.3%

Shares of NYSE:SEM opened at $15.22 on Thursday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.87. The stock has a fifty day simple moving average of $13.93 and a two-hundred day simple moving average of $13.87. Select Medical Holdings Corporation has a 12-month low of $11.65 and a 12-month high of $20.83. The stock has a market capitalization of $1.88 billion, a price-to-earnings ratio of 17.70, a PEG ratio of 0.55 and a beta of 1.28.

Select Medical (NYSE:SEMGet Free Report) last released its earnings results on Thursday, October 30th. The health services provider reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Select Medical had a return on equity of 7.41% and a net margin of 2.05%.The company’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.43 earnings per share. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. On average, research analysts anticipate that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 25th. Shareholders of record on Wednesday, November 12th were paid a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date was Wednesday, November 12th. Select Medical’s dividend payout ratio (DPR) is currently 29.07%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on SEM. Royal Bank Of Canada increased their target price on Select Medical from $16.00 to $20.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 8th. Bank of America decreased their price objective on Select Medical from $18.00 to $15.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Benchmark restated a “buy” rating on shares of Select Medical in a report on Monday, October 27th. Finally, Mizuho set a $17.00 price target on shares of Select Medical in a research note on Monday, November 3rd. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $17.80.

Get Our Latest Analysis on Select Medical

About Select Medical

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Corporation (NYSE:SEMFree Report).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.